NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice-Brief Report
- PMID: 32907369
- PMCID: PMC7571845
- DOI: 10.1161/ATVBAHA.120.314607
NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice-Brief Report
Abstract
Objective: NR4A orphan receptors have been well studied in vascular and myeloid cells where they play important roles in the regulation of inflammation in atherosclerosis. NR4A1 (nerve growth factor IB) is among the most highly induced transcription factors in B cells following BCR (B-cell receptor) stimulation. Given that B cells substantially contribute to the development of atherosclerosis, we examined whether NR4A1 regulates B-cell function during atherogenesis. Approach and Results: We found that feeding Ldlr-/- mice a Western diet substantially increased Nr4a1 expression in marginal zone B (MZB) cells compared with follicular B cells. We then generated Ldlr-/- mice with complete B- or specific MZB-cell deletion of Nr4a1. Complete B-cell deletion of Nr4a1 led to increased atherosclerosis, which was accompanied by increased T follicular helper cell-germinal center axis response, as well as increased serum total cholesterol and triglycerides levels. Interestingly, specific MZB-cell deletion of Nr4a1 increased atherosclerosis in association with an increased T follicular helper-germinal center response but without any impact on serum cholesterol or triglyceride levels. Nr4a1-/- MZB cells showed decreased PDL1 (programmed death ligand-1) expression, which may have contributed to the enhanced T follicular helper response.
Conclusions: Our findings reveal a previously unsuspected role for NR4A1 in the atheroprotective role of MZB cells.
Keywords: animals; atherosclerosis; cholesterol; diet, Western; mice.
Conflict of interest statement
None.
Figures


Similar articles
-
Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.Arterioscler Thromb Vasc Biol. 2018 May;38(5):1020-1029. doi: 10.1161/ATVBAHA.117.310467. Epub 2018 Mar 29. Arterioscler Thromb Vasc Biol. 2018. PMID: 29599136 Free PMC article.
-
Enhanced B-1 self-renewal and attenuated atherosclerotic lesion development in Cd19cre/+Ldlr-/- mice on Western-type diet.Atherosclerosis. 2025 Aug;407:120406. doi: 10.1016/j.atherosclerosis.2025.120406. Epub 2025 Jun 14. Atherosclerosis. 2025. PMID: 40544016
-
Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2316-25. doi: 10.1161/ATVBAHA.115.306171. Epub 2015 Sep 24. Arterioscler Thromb Vasc Biol. 2015. PMID: 26404487 Free PMC article.
-
Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1772-81. doi: 10.1161/ATVBAHA.116.307790. Epub 2016 Jul 14. Arterioscler Thromb Vasc Biol. 2016. PMID: 27417587 Free PMC article.
-
Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.Cardiovasc Res. 2019 Jan 1;115(1):243-254. doi: 10.1093/cvr/cvy143. Cardiovasc Res. 2019. PMID: 29917052
Cited by
-
Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):1906-1915. doi: 10.1161/ATVBAHA.124.319847. Epub 2024 Jul 18. Arterioscler Thromb Vasc Biol. 2024. PMID: 39022832 Free PMC article. Review.
-
Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling.J Immunol Res. 2024 Jul 23;2024:5009637. doi: 10.1155/2024/5009637. eCollection 2024. J Immunol Res. 2024. PMID: 39081633 Free PMC article.
-
An atherosclerotic plaque-targeted single-chain antibody for MR/NIR-II imaging of atherosclerosis and anti-atherosclerosis therapy.J Nanobiotechnology. 2021 Sep 28;19(1):296. doi: 10.1186/s12951-021-01047-4. J Nanobiotechnology. 2021. PMID: 34583680 Free PMC article.
-
NR4A1 Acts as a Novel Regulator of Platelet Activation and Thrombus Formation.Circ Res. 2025 Apr 11;136(8):809-826. doi: 10.1161/CIRCRESAHA.124.325645. Epub 2025 Mar 4. Circ Res. 2025. PMID: 40035146 Free PMC article.
-
Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.Int J Mol Sci. 2022 Mar 21;23(6):3372. doi: 10.3390/ijms23063372. Int J Mol Sci. 2022. PMID: 35328792 Free PMC article. Review.
References
-
- Nus M, Tsiantoulas D, Mallat Z. Plan B (-cell) in atherosclerosis. Eur J Pharmacol. 2017; 816:76–81. doi: 10.1016/j.ejphar.2017.09.002 - PubMed
-
- Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Murphy D, Loinard C, Binder CJ, Mallat Z. BAFF receptor deficiency reduces the development of atherosclerosis in mice–brief report. Arterioscler Thromb Vasc Biol. 2012; 32:1573–1576. doi: 10.1161/ATVBAHA.111.244731 - PubMed
-
- Nus M, Sage AP, Lu Y, Masters L, Lam BYH, Newland S, Weller S, Tsiantoulas D, Raffort J, Marcus D, et al. Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet. Nat Med. 2017; 23:601–610. doi: 10.1038/nm.4315 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials